Opinion/decision on a Paediatric investigation plan (PIP): Retsevmo, Selpercatinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0133/2023

Submitted by Anonymous (not verified) on 19 July 2024 - 14:45

Opinion/decision on a Paediatric investigation plan (PIP): Retsevmo, Selpercatinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0133/2023

Human medicines European public assessment report (EPAR): DuoPlavin, clopidogrel,acetylsalicylic acid, Date of authorisation: 14/03/2010, Revision: 31, Status: Authorised

Submitted by Anonymous (not verified) on 19 July 2024 - 13:28

Human medicines European public assessment report (EPAR): DuoPlavin, clopidogrel,acetylsalicylic acid, Date of authorisation: 14/03/2010, Revision: 31, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More